Candriam S.C.A. Edwards Lifesciences Corp Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Candriam S.C.A. holds 127,235 shares of EW stock, worth $8.42 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

127,235

Previous 200,325 36.49%

Holding current value

$8.42 Million

Previous $18.5 Million 54.63%

% of portfolio

0.05%

Previous 0.11%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$59.7 - $93.78 $4.36 Million - $6.85 Million	-73,090 Reduced 36.49%	127,235 $8.4 Million
Q2 2024 Aug 05, 2024	BUY	$84.3 - $94.31 $12.7 Million - $14.2 Million	150,662 Added 303.37%	200,325 $18.5 Million
Q1 2024 May 03, 2024	BUY	$72.54 - $95.56 $126,364 - $166,465	1,742 Added 3.64%	49,663 $4.75 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $4.37 Million - $5.51 Million	-70,824 Reduced 59.64%	47,921 $3.65 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $5.29 Million - $7.12 Million	-76,295 Reduced 39.12%	118,745 $8.23 Million
Q2 2023 Aug 08, 2023	SELL	$81.41 - $94.33 $5.6 Million - $6.49 Million	-68,754 Reduced 26.06%	195,040 $18.4 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $466,427 - $530,807	-6,281 Reduced 2.33%	263,794 $21.8 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $15 Million - $19.3 Million	-220,201 Reduced 44.91%	270,075 $20.2 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $24.7 Million - $32.2 Million	300,423 Added 158.24%	490,276 $40.5 Million
Q2 2022 Aug 03, 2022	BUY	$86.5 - $128.27 $1.21 Million - $1.8 Million	14,035 Added 7.98%	189,853 $18.1 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $2.27 Million - $2.86 Million	22,278 Added 14.51%	175,818 $20.7 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $4.1 Million - $5.04 Million	38,591 Added 33.57%	153,540 $19.9 Million
Q3 2021 Nov 09, 2021	BUY	$102.91 - $122.75 $213,126 - $254,215	2,071 Added 1.83%	114,949 $13 Million
Q2 2021 Jul 20, 2021	BUY	$83.84 - $104.76 $1.4 Million - $1.75 Million	16,688 Added 17.35%	112,878 $11.7 Million
Q4 2020 Jan 22, 2021	BUY	$71.69 - $91.23 $639,976 - $814,410	8,927 Added 10.23%	96,190 $8.78 Million
Q3 2020 Oct 19, 2020	SELL	$67.19 - $87.44 $441,707 - $574,830	-6,574 Reduced 7.01%	87,263 $6.97 Million
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $3.52 Million - $4.71 Million	61,223 Added 187.72%	93,837 $6.49 Million
Q4 2019 Jan 21, 2020	BUY	$71.7 - $82.09 $139,456 - $159,665	1,945 Added 6.34%	32,614 $8,000
Q3 2019 Oct 21, 2019	BUY	$61.55 - $75.43 $384,072 - $470,683	6,240 Added 25.54%	30,669 $7,000
Q2 2019 Aug 01, 2019	BUY	$55.74 - $64.41 $46,041 - $53,202	826 Added 3.5%	24,429 $4.49 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $46,549 - $57,110	-1,003 Reduced 4.08%	23,603 $3.62 Million
Q3 2018 Nov 07, 2018	SELL	$45.7 - $58.03 $11,927 - $15,145	-261 Reduced 1.05%	24,606 $4.28 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $477,010 - $576,458	-11,237 Reduced 31.12%	24,867 $3.62 Million
Q1 2018 May 09, 2018	BUY	$37.19 - $47.45 $183,011 - $233,501	4,921 Added 15.78%	36,104 $5.04 Million
Q4 2017 Feb 07, 2018	SELL	$33.79 - $39.39 $10,947 - $12,762	-324 Reduced 1.03%	31,183 $3.52 Million
Q3 2017 Nov 03, 2017	BUY	$36.29 - $38.83 $1.14 Million - $1.22 Million	31,507	31,507 $3.44 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

6.35M

Put Options Held

2.82M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account